Tag: Immunogenicity
-
New Tanzanian Malaria Vaccine SUM-101 Shows Strong Immune Response in Early Trials
Promising early results for SUM-101 in Tanzanian adults A new experimental malaria vaccine, SUM-101, has generated encouraging immune responses in its first human trial conducted with Tanzanian adults who have prior exposure to malaria. The study, conducted in Dar es Salaam and led by researchers including Aina-ekisha Kahatano and Maxmillian Mpina, aims to assess safety,…
-
Data Sought for Dec. 2025 COVID Vaccine Antigen Talks
Overview of the December 2025 TAG-CO-VAC Deliberations The World Health Organization’s Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to monitor the genetic and antigenic evolution of SARS-CoV-2, how the immune system responds to infection and vaccination, and how vaccines perform against circulating variants. Ahead of the December 2025 decision-making meeting, TAG-CO-VAC outlines the…
-
Data Sought for December 2025 COVID Vaccine Antigen Talks
Overview of TAG-CO-VAC and December 2025 Preparations The World Health Organization’s Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to monitor the genetic and antigenic evolution of SARS-CoV-2, immune responses to natural infection and vaccination, and how vaccines perform against circulating variants. In anticipation of its December 2025 meeting, TAG-CO-VAC outlines the data it…